26 February 2025

---

Millennium Dental Technologies Secures New U.S. Patent for Laser Periodontal Treatment

---

Millennium Dental Technologies, Inc. announced today that it has been awarded a new U.S. Patent (#12,011,326) for laser-assisted periodontal procedures associated with its LANAP protocol using the PerioLase MVP-7, a free-running, variable-pulsed Nd:YAG laser.

The announcement coincides with Gum Disease Awareness Month, which is recognized by official proclamation in all 50 states, multiple territories, and several Canadian provinces to promote early detection and treatment. Gum disease—also known as periodontal disease—affects up to 85% of adults and is the leading cause of tooth loss.

Developed for the treatment of moderate to severe periodontal disease, the minimally invasive LANAP protocol helps save natural teeth by significantly reducing harmful bacteria, preserving healthy tissue, and regenerating alveolar bone without the need for cutting or stitches.

The new patent builds on the company’s existing patented procedures for eliminating disease and regenerating bone, periodontal ligament, and cementum on a previously diseased root surface using the PerioLase MVP-7.

“This further solidifies our position as the leader in dental laser-assisted regeneration technology and innovative procedures such as the LANAP protocol,” said Robert H. Gregg II, DDS, founder, president, and chairman of the board at Millennium Dental Technologies. “Combined with our other patents, it protects years of research supporting the LANAP protocol and other proprietary laser procedures only available using our PerioLase MVP-7 dental laser.”

Other unique procedures available only with the PerioLase MVP-7 include:

• LAPIP protocol to save ailing and failing dental implants
• BLAST protocol to prevent peri-implantitis and enhance implant integration
• VAPS (Value-Added Procedures), which include dozens of soft- and hard-tissue laser techniques ranging from the treatment of TMJ, hemangiomas, and fibromas to depigmentation, hemostasis, and decontamination of tooth extraction sockets

Each year, Millennium Dental Technologies initiates its annual pledge to provide complimentary LANAP treatmentto approximately 100 patients through its collaboration with the Institute for Advanced Laser Dentistry (IALD), a non-profit educational and research organization dedicated to eradicating periodontitis. Since its inception, the annual pledge has benefited more than 1,600 patients and represents more than $16 million in free dental treatment.

Headquartered in Cerritos, CA, Millennium Dental Technologies is the developer of the LANAP protocol for the treatment of periodontal disease and the manufacturer of the PerioLase MVP-7 Nd:YAG free-running pulsed laser. By providing a comfortable experience with unique bone-building clinical results, the company’s FDA-cleared LANAP protocol removes the fear of gum disease treatment, offering a more comfortable and less invasive alternative to conventional surgery.

The company’s founding clinician, Robert H. Gregg II, DDS, continues to lead with the vision of creating better clinical outcomes for periodontal disease patients while staying true to the guiding principle: “It’s all about the patient.”

Source: www.lanap.com